 |
FDA staff question Pfizer arthritis drug benefitsUS drug reviewers on Monday questioned whether the benefits of Pfizer's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections. The Food and Drug Administration staff said the drug, cal More… |
Friday 19 April 2024
